Year-end Sale % OFF 
Abstract
With the rapid increase of antibiotic-resistant pathogens and the decline of discovery and development of new antibiotics, there is an urgent need to exploit alternative anti-infective drugs. Fungal defensin-like peptides are emerging as a class of new source of anti-infective drugs due to their potent antibacterial activity, low toxicity, and high serum stability. Fungal genome sequencing projects combined with the development of recombinant expression techniques will accelerate the discovery of fungal defensin-like peptides.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
